Sign Up to like & get
recommendations!
1
Published in 2022 at "Neurology"
DOI: 10.1212/wnl.0000000000200384
Abstract: Background and Objectives Disease-modifying therapeutic trials for genetic frontotemporal dementia (FTD) are underway, but sensitive cognitive outcome measures are lacking. The aim of this study was to identify such cognitive tests in early stage FTD…
read more here.
Keywords:
plus nacc;
pathogenic variant;
nacc ftld;
stage ... See more keywords